Type
Drug resistance in leprosy: reports from selected endemic countries. Weekly epidemiological record [Internet]. 2009;84(26):264-7. Available from: http://www.who.int/wer/2009/wer8426.pdf
Type
. Detection of RNA expression from pseudogenes and non-coding genomic regions of Mycobacterium leprae. Microbial pathogenesis. 2009;47(3):183-7.
Type
. Histoid leprosy: the impact of the entity on the postglobal leprosy elimination era. International journal of dermatology. 2009;48(6):603-10.
Type
. The role of polymorphic protein tyrosine phosphatase non-receptor type 22 in leprosy. The Journal of investigative dermatology. 2009;129(11):2726-8.
Type
. Elephantiasis, elastin, and chronic wound healing: 19th century and contemporary viewpoints relevant to hypotheses concerning lymphedema, leprosy, erysipelas, and psoriasis--review and reflections. Lymphology. 2009;42(1):19-25.
Type
. Bilateral optic neuritis in leprosy. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2009;44(2):219-20.
Type
. Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease. AIDS (London, England). 2009;23(12):1599-600.
Type
. Nasal reconstruction of the leprosy nose using costal cartilage. Otolaryngologic clinics of North America. 2009;42(3):547-55.
Type
. Evaluation of a simplified IS6110 PCR for the rapid diagnosis of Mycobacterium tuberculosis in an area with high tuberculosis incidence. Pathologie-biologie. 2011;59(3):161-5.
Type
. Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report. BMC infectious diseases [Internet]. 2009;9:75. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696458/pdf/1471-2334-9-75.pdf